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OPINION Open Access
Functional somatic disorders: discussion
paper for a new common classification for
research and clinical use
Christopher Burton1* , Per Fink2, Peter Henningsen3, Bernd Löwe4, Winfried Rief5 and on behalf of the
EURONET-SOMA Group
Abstract
Background: Functional somatic symptoms and disorders are common and complex phenomena involving both
bodily and brain processes. They pose major challenges across medical specialties. These disorders are common
and have significant impacts on patients’ quality of life and healthcare costs.
Main body: We outline five problems pointing to the need for a new classification: (1) developments in understanding
aetiological mechanisms; (2) the current division of disorders according to the treating specialist; (3) failure of current
classifications to cover the variety of disorders and their severity (for example, patients with symptoms from multiple
organs systems); (4) the need to find acceptable categories and labels for patients that promote therapeutic partnership;
and (5) the need to develop clinical services and research for people with severe disorders.
We propose ‘functional somatic disorders’ (FSD) as an umbrella term for various conditions characterised by persistent
and troublesome physical symptoms. FSDs are diagnosed clinically, on the basis of characteristic symptom patterns. As
with all diagnoses, a diagnosis of FSD should be made after considering other possible somatic and mental differential
diagnoses. We propose that FSD should occupy a neutral space within disease classifications, favouring neither somatic
disease aetiology, nor mental disorder. FSD should be subclassified as (a) multisystem, (b) single system, or (c) single
symptom. While additional specifiers may be added to take account of psychological features or co-occurring diseases,
neither of these is sufficient or necessary to make the diagnosis. We recommend that FSD criteria are written so as to
harmonise with existing syndrome diagnoses. Where currently defined syndromes fall within the FSD spectrum – and
also within organ system-specific chapters of a classification – they should be afforded dual parentage (for example,
irritable bowel syndrome can belong to both gastrointestinal disorders and FSD).
Conclusion: We propose a new classification, ‘functional somatic disorder’, which is neither purely somatic nor purely
mental, but occupies a neutral space between these two historical poles. This classification reflects both emerging
aetiological evidence of the complex interactions between brain and body and the need to resolve the historical split
between somatic and mental disorders.
Keywords: Classification, Functional disorders, Medically unexplained symptoms, Psychosomatic medicine, Somatoform
disorders, Psychophysiologic disorders, Somatic symptom disorder, Bodily distress
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Background
Here we propose a new classification: ‘functional somatic
disorder’ (FSD). We apply this term to disorders charac-
terised by certain patterns of physical symptoms, rather
than a single consistent cause or pathology. We under-
stand these disorders as having complex aetiological
mechanisms, which may vary between individuals with
similar symptoms and which are the subject of continu-
ing research. These disorders are common and present
in around one-third of healthcare consultations in both
primary care [1] and specialist practice [2].
This paper is based on discussions by members of the
informal European research network EURONET-SOMA
(European Network to Improve Diagnostic, Treatment
and Health Care for Patients with Persistent Somatic
Symptoms) [3]. The network’s discussions and outputs
so far have included research agendas for FSD [4], position
statements on outcome measures [5] and aetiological
mechanisms [6] and a comparison of healthcare for per-
sistent somatic symptoms across Europe [7, 8]. The pur-
pose of the discussions, which have been conducted since
2016 and are presented in the current paper, was to create
a common framework for the classification of FSDs,
including the various functional somatic syndromes, for
research and clinical use. The authors constitute the core
group, but a broader group of people has contributed at
some of the face-to-face meetings.
Rationale for a new classification
We base the argument for a new classification on five
factors. To some extent these overlap and some have
been rehearsed before [9–12]. Nevertheless, the contin-
ued emergence of critiques of current and proposed
classifications suggests that problems relating to the
classification of FSDs have not yet been adequately re-
solved. The five factors are:
Developments in understanding the aetiological mech-
anisms underlying functional symptoms and FSD.
The problem of division of FSDs according to the treat-
ing specialist (e.g. irritable bowel syndrome, IBS, in gastro-
enterology, or somatic symptom disorder in Psychiatry).
Failure of current classifications to cover the variety of
disorders and the range of severity within disorders.
The need to find acceptable illness categories and la-
bels for (and with) patients, which promote therapeutic
partnership.
The need to develop clinical services and further
research for people with severe FSDs.
Current classifications
At present, two major clinical classification systems in-
volve FSDs: the World Health Organisation’s International
Classification of Diseases (ICD) [13] and the American
Psychiatric Association’s Diagnostic and Statistical Manual
(DSM) [14]. We also consider a recent research classifica-
tion: bodily distress syndrome (BDS) [15] and proposals
for the next version of ICD for primary healthcare (ICD-
PHC) [16].
ICD includes all somatic and mental conditions, in-
cluding – in the versions for primary care – individual
or non-specific symptoms. DSM is restricted to the
domain of psychiatry and does not have sections for
organ or physiological systems (e.g. the gastrointestinal
system) in the same way as ICD.
ICD-10 includes individual functional somatic syn-
dromes, such as IBS or fibromyalgia, placed within organ-
specific chapters. However, at the same time, so-called
‘medically unexplained symptoms’ – either multiple and
across organ systems, or single and related to one organ
system – are coded as ‘somatoform’ or ‘dissociative neuro-
logical disorders’ within the mental disorders chapter.
Their main feature is “repeated presentation of physical
symptoms … in spite of repeated negative findings and re-
assurances by doctors that the symptoms have no physical
basis.” This emphasis on “no physical basis” for symptoms
is removed in the proposal for ICD-11, which instead in-
troduces bodily distress disorder (BDD) [17]. BDD is
“characterized by the presence of bodily symptoms that
are distressing to the individual and excessive attention di-
rected toward the symptoms …” . BDD in ICD-11, as well
as somatic symptom disorder in DSM-5 [14], focus on the
psychological and emotional features relating to physical
symptoms as “excessive thoughts, feelings, or behaviours
related to the somatic symptoms or associated health con-
cerns”. None of these recent classifications make stipula-
tions about the presence or absence of somatic disease.
In contrast, BDS [15, 18] comprises clusters of symp-
toms according to organ or physiological system and
does not include any requirement for symptoms to be
accompanied by psychobehavioural features. It does not
include or exclude somatic disease, but states that symp-
toms should not be better explained by other conditions.
In these regards, BDS resembles the specialty-specific
functional somatic syndrome diagnoses such as IBS and
fibromyalgia, which are also based on physical symptoms
reports. The ICD and DSM criteria were originally based
on theories about psychological and emotional factors in
illness and, later on, consensus based descriptions, with
field trials testing the proposals only thereafter. How-
ever, the BDS model was, from the start, derived empir-
ically from clinical descriptive and epidemiological
studies of physical symptoms. The work underpinning
BDS is reflected in proposals for the next version of
ICD-PHC. This introduces, within the mental disorders,
a category of ‘bodily stress syndrome’ [19]. This proposes
a specific number of symptoms not otherwise explained
and largely related to a postulated underlying mechan-
ism of autonomic arousal [16].
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In parallel with these mental classifications across
body systems, several specialty-specific classifications
continue to evolve, including criteria for functional
gastro-intestinal disorders [20] and fibromyalgia [21].
Developments in understanding the aetiological
mechanisms underlying functional symptoms and
functional somatic disorders
There is increasing recognition that FSDs involve multiple
processes. While no single aetiological mechanism has been
identified for FSDs, studies support the involvement of a
variety of processes. Current hypotheses include processes
involving both the body (e.g., immune system [22], auto-
nomic nervous system [23], hypothalamo-pituitary axis
[24], mitochondrial function [25]) and the brain and mind
(processing and perception of bodily signals [6], central sen-
sitisation [26], psychological adaptation [27]). This involve-
ment of multiple processes is thought to be shared across
individual syndromes [26, 28], even though the specific
processes involved may differ between individuals and syn-
dromes. A common classification may thus strengthen re-
search into aetiological mechanisms in functional disorders
and must be capable of further evolution in the light of new
scientific knowledge.
Division of functional somatic disorders according to the
most commonly treating specialist
For over 20 years, it has been recognised that there is a
rather arbitrary delimitation of single, specialty-specific
functional somatic syndromes, such as IBS or fibromyal-
gia, and that there is great overlap between them in
terms of shared symptoms and i patients fulfilling cri-
teria for more than one syndrome [11]. Nevertheless,
these remain useful constructs for specialists, generalists
and for many patients suffering from symptoms from
predominantly one organ or physiological system. There
is, thus, a good case that they should be retained and
that, where possible, new classifications for FSD should
harmonise with these specialty-specific syndromes.
Failure of any current classifications to include the variety
of disorders and the range of severity within disorders
The current separation of syndromes into somatic or
mental sections of classifications means that there is no
overall category for FSDs. This is a particular problem
when patients experience multiple symptoms from mul-
tiple organ systems (meeting criteria for more than one
functional syndrome or for multiorgan-type BDS) [15],
but do not demonstrate the psychological features neces-
sary for a diagnosis in the mental health sections of the
ICD-11 or DSM-5.
The need to find acceptable illness categories and labels
for (and with) patients, which promote therapeutic
partnership
There is increasing.recognition of the importance of
concordant views about illness between patients and
their clinicians [29, 30]. Current classifications, which
classify some FSDs as somatic and others as mental dis-
orders, cause problems for patients and clinicians. One
element of acceptability is the issue of the names used
[10, 31, 32]. The term ‘functional’ has clear advantages,
although we recognise the unfortunate legacy that it
may be used pejoratively by some clinicians [33]. ‘Bodily
distress’ is more problematic in (British) English because
it implies a lack of mental resilience [10], although that
is not the case in several European languages. While the
term ‘medically unexplained symptoms’ continues to be
used by professionals (especially in primary care), we
deprecate its use [10, 34], firstly because it is almost
always used about, rather than with, patients. Secondly,
it emphasises – rather than addresses – the unhelpful
explanatory gap between patients and professionals [35].
The need to develop services and research into
treatments for people with complex functional somatic
disorders
Patients with FSDs, particularly those with complex or
multisystem FSDs, frequently experience long periods
during which conditions are ruled out but no working
diagnosis is provided. Having a classification for FSDs
that is acceptable across various medical specialties, in-
cluding primary care, would allow earlier discussion of
what a patient has (or might have, when an FSD is still
part of a differential diagnosis) rather than waiting for a
diagnosis of exclusion, as is currently the case. A similar
argument was advanced in relation to the ICD-11 classi-
fications [16].
Such a non-stigmatising and useful diagnostic classifi-
cation may facilitate an early diagnosis and diminish
potential harmful examinations and fruitless symptom
treatment approaches. It would also aid the identifica-
tion of patients for current and potentially future treat-
ments and research.
Additional advantages of this classification are that it
could be applied within clinical databases and registries
and used to teach students and trainee doctors, where
the subject is currently poorly understood [36].
Purpose of this proposed classification
In view of the five factors discussed above, we aim to
classify FSD in a way that will facilitate communication
between clinical specialties and bridge the gap between
functional somatic syndromes in different sections of the
ICD. Furthermore, such a classification will improve rep-
resentation in epidemiological studies and studies on
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health care relevance and help to establish correspond-
ing research programs and the provision of syndrome-
specific and overarching treatment approaches.
Key features of the proposed classification
Functional somatic disorders
We propose the term ‘functional somatic disorders’ as
an umbrella term for various conditions characterised by
persistent and troublesome physical symptoms that are
accompanied by impairment or disability. We under-
stand these symptoms as reflecting the integration of
bodily and brain functions and dysfunctions. They are
the product of complex interactions, involving multiple
biological and psychosocial factors. Diagnosis of FSDs
should be made based on the symptoms, not on the
presence or absence of specific biological or psychosocial
contributors to symptoms.
Neutral categorical space
FSDs should occupy a neutral space within disease clas-
sifications, favouring neither a somatic disease aetiology,
nor a mental disorder. This reflects their complex nature
and causality and is analogous to pain disorders within
ICD-11 [37]. The FSD spectrum includes several estab-
lished syndromes, such as IBS and fibromyalgia. Where
such syndromes fall within the FSD spectrum and also
within organ system-specific chapters of a classification,
they should be afforded dual parentage (e.g. IBS can
belong to both gastrointestinal disorders and FSD). We
also recommend that, where possible, FSD criteria are
written to harmonise with existing syndrome diagnoses.
We have adopted this position to encourage clinicians to
think of syndromes as both belonging within their
specialist domain and within the broader FSD umbrella,
rather than exclusively one or the other. We believe that
this degree of flexibility is appropriate in the light of
evolving scientific knowledge about both peripheral and
central processes underpinning symptoms and disorders.
Making a diagnosis
The diagnosis of FSDs is essentially clinical. There are
no tests that can consistently be used to diagnose the
condition(s); instead, diagnosis should be established by
a characteristic symptom pattern. As with all diagnoses,
it should be made after considering other possible med-
ical and psychiatric differential diagnoses. The patient
may, however, have both FSD and another somatic dis-
ease or mental or behavioural disorder. For a diagnosis
of FSD to be present, symptoms compatible with the
diagnosis must have been present for at least 3 months.
Symptoms within system clusters
Within the FSD classification, physical symptoms are
grouped within clusters broadly linked to organ or
physiological systems. Currently, we propose six system
clusters, derived from clinical descriptive and epidemio-
logical studies, as well as having face validity to many clini-
cians: musculoskeletal, gastrointestinal, cardiorespiratory,
genitourinary, nervous system and fatigue-related. The
presence of symptoms across multiple bodily systems is a
key element of the proposed classification.
Relationship to psychological or behavioural features
Patients with FSDs may also have dysfunctional psycho-
logical or behavioural features accompanying the bodily
symptoms. These features, in themselves, may cause dis-
tress and contribute to the symptoms (for instance,
through positive feedback loops between symptoms and
psychological features); therefore an option is needed to
describe these additional treatment needs. Dysfunctional
psychological or behavioural features are neither neces-
sary nor sufficient for a diagnosis of FSD, but may be
used as an additional specifier within categories.
Categories of functional somatic disorder
Within the umbrella category of FSD, we propose three
categories based on the pattern of physical symptoms
and organ or physiological systems involved: (1) multi-
system, (b) single system and (c) single symptom. These
are summarised in Fig. 1.
FSD: multisystem type
This is characterised by patients experiencing, at one
point in time and over time, multiple persistent and
troublesome bodily symptoms across multiple organ or
physiological systems that meet further specified classifi-
cation criteria.
Further work is needed to specify the number of sys-
tems and how to grade severity: this may be continuous
or categorical, involving both number of symptoms and
number of systems. As an example, BDS uses three or
more symptoms in three or more body systems [18].
FSD: single system type
This represents a persistent and troublesome cluster of
symptoms that predominantly occur in relation to one
bodily system. The current set of symptom clusters is:
musculoskeletal, gastrointestinal, cardiorespiratory, geni-
tourinary, nervous system and fatigue-related.
These clusters map closely to some of the existing
functional somatic syndromes (such as IBS, fibromyalgia,
etc.).
FSD: single symptom type
This represents an isolated persistent and troublesome
symptom (e.g., headache, dizziness, tinnitus). Such single
symptoms may or may not, like the other types of FSD
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referred to above, be associated with dysfunctional psy-
chobehavioural features or symptoms.
Additional specifiers
In addition to the three categories, we propose two spec-
ifiers that may be used to more accurately characterise
disorders or to direct treatment:
1. Presence of psychological or behavioural features
(cognitive, affective or behavioural) that are dysfunc-
tional; i.e. they cause distress beyond the distress caused
by the symptoms themselves; and.
2. Occurrence in interaction with symptom-congruent
medical condition (e.g. fibromyalgia in a person with
rheumatoid arthritis).
Relationship of specifiers to diagnosis
The presence or absence of the specifiers is not neces-
sary to diagnose an FSD. In some situations, it may be
appropriate to use one or more of them to form more
stringent criteria for practice or research.
Selection of psychological/behavioural characteristics for
inclusion as specifiers
Work is in progress to produce a shortlist of characteristics
for inclusion. Current work has identified many possible
candidates, including health anxiety, catastrophisation, at-
tentional symptom focus, somatosensory amplification,
avoidance and safety-seeking behaviour, a general construct
of ‘having a weak body’, attributional style, negative
affectivity and dissatisfaction with prior health care. The
features included in the definition of DSM-5 somatic symp-
tom disorder are not a reliable guidance here. Priority will
be given to items that are prognostic in terms of severity/
duration or guiding treatment. These features may or may
not be part of an additional mental comorbidity.
Discussion
Our proposed classification of functional somatic
disorder is neither purely somatic nor purely mental; it
occupies a ‘neutral space’ between these two historical
poles. It recognises the complex interplay between body
and brain that occurs during the transition from acute
to persistent somatic symptoms [6], regardless of
whether the symptoms originate in well-defined somatic
diseases or arise independently.
Importantly, this proposed diagnosis, based on the
symptoms themselves, does not require psychological
diagnostic criteria to be present. This is important for
clinicians (putting the diagnosis within reach of all spe-
cialist areas) and for patients (many of whom are wary
about clinicians being ‘too psychological’ too early on in
the diagnostic process). By including co-existing psycho-
logical symptoms or somatic illnesses, it can be given an
extra level of depth of classification.
Fig. 1 Structure of the proposed classification showing the relationship between main category, sub-categories and additional features
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We believe that the ‘either’ (mental)/‘or’ (somatic) can
finally be resolved by this new diagnostic proposal and
gives way to a ‘both’, which is more contemporary and
scientifically correct. We hope that with it, the unfair
and harmful stigmatisations of patients with functional
symptoms will diminish and the diagnosis will become
more acceptable for people living with FSDs. At the
same time, it may help clinicians to remain aware of the
high levels of mental comorbidity, in terms of anxiety
and depression in people with FSDs [16], which may
otherwise remain unrecognised. Notably, our proposal
must be further synchronised with other proposals for
classification. Just recently, the World Health Assembly
adopted the ICD-11 proposal, including the group of
chronic pain diagnoses. The ‘chronic primary pain’ cat-
egory [38] includes many FSDs also mentioned in this
manuscript, although the focus of this classification pro-
posal is more on pain as a leading symptom [37]. Both
our proposal and the recent pain developments are
highly descriptive approaches, avoiding any dualism be-
tween psychological versus biological causality. There-
fore, our suggested classification of functional somatic
syndromes could be located in close proximity to the
chronic pain classification and sleeping disorders in
ICD-11. However, we see some weaknesses in focusing
only on pain diagnosis, even if many other somatic
symptoms are present. For instance, diagnosing IBS as a
pure pain disorder does not seem to adequately describe
this syndrome. ICD-11 offers the opportunity to use
double parenting to solve the issue of overlapping cat-
egories. Harmonisation of these proposed classifications
should be the subject of future work that explicitly en-
courages the inclusion of different types of symptoms.
Going forward, our diagnostic proposal must prove it-
self in clinical and scientific practice. We are confident,
however, that this proposal is currently the best solution,
while remaining open to future scientific developments.
We hope that it can be acceptable to patients, scientists
and physicians from all fields of medicine and that it will
stimulate further research efforts on a national and
international level.
Conclusion
We propose a new classification of functional somatic
disorder that is neither purely somatic nor purely men-
tal, but occupies a neutral space between these two his-
torical poles. This reflects both emerging aetiological
evidence of the complex interactions between brain and
body and the need to resolve the historical split between
somatic and mental disorders.
Acknowledgements
Discussions about the proposed classification took place at meetings of the
wider EURONET-SOMA group as described in the manuscript. Members of
the group were invited to comment on a pre-final draft.
Authors’ contributions
All authors contributed equally to the discussions leading to the proposed
classification. CB drafted initial and succeeding versions of the manuscript.
All authors contributed to the revisions at each stage and all authors read
and approved the final manuscript.
Authors’ information
CB is a general practitioner, PF is a psychiatrist, PH and BL are specialists in
psychosomatic medicine and WR is a psychologist.
Funding
No external funding was used in writing this manuscript.
Availability of data and materials
Not applicable.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Author details
1Academic Unit of Primary Medical Care, University of Sheffield, Northern
General Hospital, Samuel Fox House, Sheffield S5 7AU, UK. 2Research Clinic
for Functional Disorders and Psychosomatics, Aarhus University Hospital,
Aarhus, Denmark. 3Department of Psychosomatic Medicine and
Psychotherapy, University Hospital Rechts der Isar, Technical University of
Munich, Munich, Germany. 4Department of Psychosomatic Medicine and
Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg,
Germany. 5Department of Clinical Psychology and Psychotherapy, University
of Marburg, Marburg, Germany.
Received: 25 September 2019 Accepted: 27 January 2020
References
1. Haller H, Cramer H, Lauche R, Dobos G. Somatoform disorders and
medically unexplained symptoms in primary care. Dtsch Arztebl Int.
2015;112:279–87.
2. Nimnuan C, Hotopf M, Wessely S. Medically unexplained symptoms: an
epidemiological study in seven specialities. J Psychosom Res. 2001;51:361–7.
3. Weigel A, Husing P, Kohlmann S, Lehmann M, Shedden-Mora M, Toussaint
A, et al. A European research network to improve diagnosis, treatment and
care for patients with persistent somatic symptoms: work report of the
EURONET-SOMA conference series. J Psychosom Res. 2017;97:136–8.
4. van der Feltz-Cornelis CM, Elfeddali I, Werneke U, Malt UF, Van den Bergh O,
Schaefert R, et al. A European research agenda for somatic symptom
disorders, bodily distress disorders, and functional disorders: results of an
estimate-talk-estimate Delphi expert study. Front Psychiatr. 2018;9:151.
5. Rief W, Burton C, Frostholm L, Henningsen P, Kleinstauber M, Kop WJ, et al.
Core outcome domains for clinical trials on somatic symptom disorder,
bodily distress disorder, and functional somatic syndromes: European
network on somatic symptom disorders recommendations. Psychosom
Med. 2017;79:1008–15.
6. Henningsen P, Gundel H, Kop WJ, Lowe B, Martin A, Rief W, et al. Persistent
physical symptoms as perceptual dysregulation: a neuropsychobehavioral
model and its clinical implications. Psychosom Med. 2018;80:422–31.
7. Kohlmann S, Lowe B, Shedden-Mora MC. Health care for persistent somatic
symptoms across Europe: a qualitative evaluation of the EURONET-SOMA
expert discussion. Front Psychiatry. 2018;9:646.
8. EURONET-SOMA. https://www.euronet-soma.eu. Accessed 20 Jan 2020.
9. Rief W, Isaac M. The future of somatoform disorders: somatic symptom
disorder, bodily distress disorder or functional syndromes? Curr Opin
Psychiatr. 2014;27:315–9.
10. Creed F, Guthrie E, Fink P, Henningsen P, Rief W, Sharpe M, et al. Is there a
better term than ‘medically unexplained symptoms’? J Psychosom Res.
2010;68:5–8.
Burton et al. BMC Medicine           (2020) 18:34 Page 6 of 7
11. Wessely S, Nimnuan M, Sharpe M. Functional somatic syndromes: one or
many. Lancet. 1999;354:936–9.
12. Kroenke K, Sharpe M, Sykes R. Revising the classification of somatoform
disorders: key questions and preliminary recommendations. Psychosomatics.
2007;48:277–85.
13. World Health Organization (WHO). International statistical classification of
diseases and related health problems (11th revision). Geneva: WHO; 2018.
14. American Psychiatric Association (APA). Diagnostic and statistical manual of
mental disorders (DSM-5). Washington, DC: APA; 2013.
15. Fink P, Schroder A. One single diagnosis, bodily distress syndrome,
succeeded to capture 10 diagnostic categories of functional somatic
syndromes and somatoform disorders. J Psychosom Res. 2010;68:415–26.
16. Goldberg DP, Reed GM, Robles R, Bobes J, Iglesias C, Fortes S, et al. Multiple
somatic symptoms in primary care: a field study for ICD-11 PHC, WHO’s
revised classification of mental disorders in primary care settings. J
Psychosom Res. 2016;91:48–54.
17. Gureje O, Reed GM. Bodily distress disorder in ICD-11: problems and
prospects. World Psychiatry. 2016;15:291–2.
18. Fink P, Toft T, Hansen MS, Ornbol E, Olesen F. Symptoms and syndromes of
bodily distress: an exploratory study of 978 internal medical, neurological,
and primary care patients. Psychosom Med. 2007;69:30–9.
19. Lam TP, Goldberg DP, Dowell AC, Fortes S, Mbatia JK, Minhas FA, et al.
Proposed new diagnoses of anxious depression and bodily stress syndrome in
ICD-11-PHC: an international focus group study. Fam Pract. 2013;30:76–87.
20. Drossman DA, Hasler WL. Rome IV – functional GI disorders: disorders of
gut–brain interaction. Gastroenterology. 2016;150:1257–61.
21. Wolfe F, Clauw DJ, Fitzcharles M-A, Goldenberg DL, Häuser W, Katz RL, et al.
2016 revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin
Arthritis Rheum. 2016;46:319–29.
22. Russell A, Hepgul N, Nikkheslat N, Borsini A, Zajkowska Z, Moll N, et al.
Persistent fatigue induced by interferon-alpha: a novel, inflammation-based,
proxy model of chronic fatigue syndrome. Psychoneuroendocrinology.
2019;100:276–85.
23. Rizzi M, Radovanovic D, Santus P, Airoldi A, Frassanito F, Vanni S, et al.
Influence of autonomic nervous system dysfunction in the genesis of sleep
disorders in fibromyalgia patients. Clin Exp Rheumatol. 2017;35(Suppl 105):
74–80.
24. Nijs J, Meeus M, Van Oosterwijck J, Ickmans K, Moorkens G, Hans G, et al. In
the mind or in the brain? Scientific evidence for central sensitisation in
chronic fatigue syndrome. Eur J Clin Investig. 2012;42:203–12.
25. Tomas C, Newton J. Metabolic abnormalities in chronic fatigue syndrome/
myalgic encephalomyelitis: a mini-review. Biochem Soc Trans. 2018;46:547–53.
26. Bourke JH, Langford RM, White PD. The common link between functional
somatic syndromes may be central sensitisation. J Psychosom Res. 2015;78:
228–36.
27. McAndrew LM, Crede M, Maestro K, Slotkin S, Kimber J, Phillips LA. Using the
common-sense model to understand health outcomes for medically
unexplained symptoms: a meta-analysis. Health Psychol Rev. 2018;13:427–46.
28. Nimnuan C, Rabe-Hesketh S, Wessely S, Hotopf M. How many functional
somatic syndromes? J Psychosom Res. 2001;51:549–57.
29. McAndrew LM, Friedlander ML, Alison Phillips L, L Santos S, Helmer DA.
Concordance of illness perceptions: The key to improving care of medically
unexplained symptoms. J Psychosom Res. 2018;111:140–2.
30. Burton C, Lucassen P, Aamland A, TO H. Explaining symptoms after negative
tests: towards a rational explanation. J R Soc Med. 2015;108:84–8.
31. Picariello F, Ali S, Moss-Morris R, Chalder T. The most popular terms for
medically unexplained symptoms: the views of CFS patients. J Psychosom
Res. 2015;78:420–6.
32. Marks EM, Hunter MS. Medically unexplained symptoms: an acceptable
term? Br J Pain. 2015;9:109–14.
33. Stone J, Wojcik W, Durrance D, Carson A, Lewis S, MacKenzie L, et al. What
should we say to patients with symptoms unexplained by disease? The
‘number needed to offend’. BMJ. 2002;325:1449–50.
34. Rosendal M, Olde Hartman TC, Aamland A, van der Horst H, Lucassen P,
Budtz-Lilly A, et al. ‘Medically unexplained’ symptoms and symptom
disorders in primary care: prognosis-based recognition and classification.
BMC Fam Pract. 2017;18:18.
35. Johansen M-L, Risor MB. What is the problem with medically unexplained
symptoms for GPs? A meta-synthesis of qualitative studies. Patient Educ
Couns. 2017;100:647–54.
36. Shattock L, Williamson H, Caldwell K, Anderson K, Peters S. ‘They’ve just got
symptoms without science’: medical trainees’ acquisition of negative
attitudes towards patients with medically unexplained symptoms. Patient
Educ Counsel. 2013;91:249–54.
37. Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, et al. Chronic
pain as a symptom or a disease: the IASP classification of chronic Ppain for
the international classification of diseases (ICD-11). Pain. 2019;160:19–27.
38. Nicholas M, Vlaeyen JWS, Rief W, Barke A, Aziz Q, Benoliel R, et al. The IASP
classification of chronic pain for ICD-11: chronic primary pain. Pain. 2019;
160:28–37.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Burton et al. BMC Medicine           (2020) 18:34 Page 7 of 7
